A Mahli

657 total citations
21 papers, 472 citations indexed

About

A Mahli is a scholar working on Epidemiology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, A Mahli has authored 21 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Pharmacology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in A Mahli's work include Liver Disease Diagnosis and Treatment (11 papers), Hops Chemistry and Applications (6 papers) and Alcohol Consumption and Health Effects (6 papers). A Mahli is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hops Chemistry and Applications (6 papers) and Alcohol Consumption and Health Effects (6 papers). A Mahli collaborates with scholars based in Germany, Switzerland and United States. A Mahli's co-authors include Claus Hellerbrand, Anja‐Katrin Bosserhoff, Wolfgang E. Thasler, Martina Müller, K Freese, A. Koch, Ralf Weiskirchen, Peter Dietrich, Sabine Weiskirchen and Sven Arke Lang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Journal of Hepatology.

In The Last Decade

A Mahli

20 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Mahli Germany 12 193 158 126 72 71 21 472
Simon Bucher France 13 138 0.7× 144 0.9× 98 0.8× 63 0.9× 52 0.7× 19 407
Xiaoyan Qiang China 6 194 1.0× 188 1.2× 93 0.7× 140 1.9× 45 0.6× 9 480
Tingying Jiao China 11 230 1.2× 131 0.8× 75 0.6× 110 1.5× 20 0.3× 15 467
Robert Win Maw Min United States 6 147 0.8× 182 1.2× 179 1.4× 51 0.7× 33 0.5× 7 423
K Freese Germany 9 206 1.1× 105 0.7× 46 0.4× 58 0.8× 32 0.5× 17 373
Mohamed O. Mahmoud Egypt 13 200 1.0× 100 0.6× 38 0.3× 55 0.8× 47 0.7× 24 575
Jianzhi Wu China 15 195 1.0× 200 1.3× 90 0.7× 28 0.4× 28 0.4× 25 483
Xingkai Liu China 15 366 1.9× 162 1.0× 50 0.4× 116 1.6× 72 1.0× 39 692
Virginia Gutiérrez‐de Juan Spain 7 181 0.9× 129 0.8× 44 0.3× 57 0.8× 30 0.4× 8 369
Yichao Du China 12 161 0.8× 72 0.5× 56 0.4× 49 0.7× 32 0.5× 24 350

Countries citing papers authored by A Mahli

Since Specialization
Citations

This map shows the geographic impact of A Mahli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Mahli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Mahli more than expected).

Fields of papers citing papers by A Mahli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Mahli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Mahli. The network helps show where A Mahli may publish in the future.

Co-authorship network of co-authors of A Mahli

This figure shows the co-authorship network connecting the top 25 collaborators of A Mahli. A scholar is included among the top collaborators of A Mahli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Mahli. A Mahli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mushtaq, Gohar, et al.. (2023). A case of concomitant leukemoid reaction and mucormycosis in a patient with severe COVID-19 infection. SHILAP Revista de lepidopterología. 48(4). 446–450.
2.
Mahli, A, Wolfgang E. Thasler, Martin Biendl, & Claus Hellerbrand. (2023). Hop-derived Humulinones Reveal Protective Effects in in vitro Models of Hepatic Steatosis, Inflammation and Fibrosis. Planta Medica. 89(12). 1138–1146. 2 indexed citations
3.
Seitz, Tatjana, Christina Hackl, K Freese, et al.. (2021). Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells. Cancers. 13(3). 511–511. 24 indexed citations
4.
Mahli, A, Tatjana Seitz, K Freese, et al.. (2019). Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro. Cells. 8(5). 457–457. 22 indexed citations
5.
6.
Mahli, A, A. Koch, Tobias S. Schiergens, et al.. (2018). Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. Laboratory Investigation. 98(12). 1614–1626. 21 indexed citations
7.
Mahli, A, et al.. (2018). Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism. Pathology - Research and Practice. 214(10). 1700–1706. 3 indexed citations
8.
Mahli, A, Wolfgang E. Thasler, & Claus Hellerbrand. (2018). Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro. Toxicology Mechanisms and Methods. 29(3). 219–223. 4 indexed citations
9.
Mahli, A, M Saugspier, A. Koch, et al.. (2017). ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis. Gut. 67(4). 746–756. 49 indexed citations
10.
Dietrich, Peter, K Freese, A Mahli, et al.. (2017). Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option. Oncotarget. 9(3). 3605–3618. 29 indexed citations
11.
Mahli, A & Claus Hellerbrand. (2016). Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease. Digestive Diseases. 34(Suppl. 1). 32–39. 44 indexed citations
12.
Mahli, A, K Freese, Andreas Teufel, et al.. (2016). Analysis of molecular mechanisms of 5-fluorouracil-induced hepatic steatosis and inflammation in vitro and in mice. Zeitschrift für Gastroenterologie. 54(12). 1343–1404. 2 indexed citations
13.
Mahli, A, et al.. (2016). Analysis of Molecular Mechanisms of 5-Fluorouracil Induced Steatosis and Inflammation in Vitro and in Mice. Journal of Hepatology. 64(2). S234–S234. 2 indexed citations
14.
Mahli, A, et al.. (2016). Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis. Zeitschrift für Gastroenterologie. 54(12). 1343–1404. 1 indexed citations
15.
Mahli, A, Wolfgang E. Thasler, Eleonora Patsenker, et al.. (2015). Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro. Oncotarget. 6(39). 41464–41478. 26 indexed citations
16.
Weiskirchen, Ralf, A Mahli, Sabine Weiskirchen, & Claus Hellerbrand. (2015). The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Frontiers in Physiology. 6. 140–140. 44 indexed citations
17.
Koch, A., Sven Arke Lang, Peter J. Wild, et al.. (2015). Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells. Oncotarget. 6(32). 32748–32760. 76 indexed citations
18.
Mahli, A, A. Koch, Anja Lechner, et al.. (2015). Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats. Clinical Phytoscience. 1(1). 41 indexed citations
19.
Mahli, A, Eleonora Patsenker, Sarina Müller, et al.. (2015). Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro. Zeitschrift für Gastroenterologie. 53(12). 2 indexed citations
20.
Mahli, A, et al.. (2015). Identification of cytochrome CYP2E1 as critical mediator of alcohol effects on steatotic hepatocytes. Zeitschrift für Gastroenterologie. 53(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Bucher Breakdown of academic impact, for papers by Xiaoyan Qiang Breakdown of academic impact, for papers by Tingying Jiao Breakdown of academic impact, for papers by Robert Win Maw Min Breakdown of academic impact, for papers by K Freese Breakdown of academic impact, for papers by Mohamed O. Mahmoud Breakdown of academic impact, for papers by Jianzhi Wu Breakdown of academic impact, for papers by Xingkai Liu Breakdown of academic impact, for papers by Virginia Gutiérrez‐de Juan Breakdown of academic impact, for papers by Yichao Du
Rankless by CCL
2026